Olanzapine Treatment of Patients With Bipolar I Disorder

Clinical trial NCT00510146 · COMPLETED

Trial details

NCT number: NCT00510146
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Depression, Bipolar

Start date: 2007-08-01
Primary completion: 2010-03-01
Enrollment: 514

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.